Changes of GCF Levels of RANKL and Osteoprotegerin in Postmenopausal Osteoporosis
Chronic Periodontitis
About this trial
This is an interventional screening trial for Chronic Periodontitis focused on measuring Bisphosphonate, osteoporosis, RANKL, OPG, periodontitis
Eligibility Criteria
Inclusion Criteria:
- Women with T scores less than -2.5 (groups A and C)
- The periodontitis patients were selected based on the radiographical evidence of bone loss, presence of four or more sites with bleeding on probing (BOP), ≥5 mm pocket depth (PD) and ≥6 mm clinical attachment loss (CAL).
- The clinically healthy control groups were selected on the basis of no radiographic bone loss or CAL and PD≤3 mm.
Exclusion Criteria:
- Any known systemic disease rather than osteoporosis
- Smoking
- Antibiotic therapy within the last 3 months
- Periodontal treatment within the last 6 months.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Active Comparator
Active Comparator
Active Comparator
Active Comparator
group A
group B
group C
group D
periodontal phase 1 therapy consisted of scaling and root planning, bisphosphonate therapy (zoledronic acid), gingival crevicular fluid collection
periodontal phase 1 therapy consisted of scaling and root planning, no bisphosphonate therapy,gingival crevicular fluid collection
no periodontal phase 1 therapy, bisphosphonate therapy (zoledronic acid), gingival crevicular fluid collection
no periodontal phase 1 therapy, no bisphosphonate therapy,gingival crevicular fluid collection